TODAY'S HEADLINES
The American Heart Association and other health organizations should consider depression as a risk factor for adverse outcomes in patients with acute coronary syndrome, according to a recent report published in Circulation, the Journal of the American Heart Association. » More |
|
FDA has approved hyaluronic acid injection (Monovisc, Anika Therapeutics), a single-injection supplement to synovial fluid of the osteoarthritic joint, for the treatment of pain and the improvement of joint mobility in patients with osteoarthritis of the knee. » More |
|
Researchers at The Ohio State University Wexner Medical Center are one of 18 clinical research centers taking part in a national study to establish guidelines for safely stepping down treatment in patients whose asthma is well controlled. » More |
|
Check out the new and improved iPad app for Drug Topics! This app features tons of interactive content and a better way to view our magazine. All issues are completely free! » More |
Continuing Education
Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
